by Collectif | 15 Nov, 2015 | Bioethics press synthesis | End of life
Laura-Emily, the 24 year-old Belgian girl who should have undergone euthanasia on 24 September due to “uncontrollable, intolerable and therefore incurable mental suffering” has eventually decided to continue to live. This was revealed in “24 & ready to die”, an...
by Collectif | 11 Nov, 2015 | Bioethics press synthesis | Embryo research and alternatives
Alexandra Henrion-Caude, geneticist and Inserm research director at Necker Hospital intends to analyse “genetic editing”and applications made possible with the CRISPR technique. This technique is “revolutionary” because it“can modify DNA simply with remarkable...
by Collectif | 11 Nov, 2015 | Bioethics press synthesis | Embryo research and alternatives
The American subsidiary, Ocata therapeutics, previously known as ACT (Advanced Cell Technology), which has come under scrutiny for its use of human embryo cells, has just been taken over by Japanese group, Astellas Pharma. “Despite being a small company,”...
by Collectif | 11 Nov, 2015 | Bioethics press synthesis | Embryo research and alternatives
A team of scientists at the CIRA (Centre for IPS cells Research and Application) at the University of Kyoto in Japan has announced that the launch of the clinical trial on potential treatment for Parkinson’s disease is being delayed on safety grounds (Cf. Gènéthique...
by Collectif | 9 Nov, 2015 | Bioethics press synthesis | End of life
In Quebec, palliative care centres have come under threat since the enactment of the law on “medically assisted dying”, MAD, dated June 2014 (Cf. Gènéthique du 10 juin 2014). Although law 52 allows palliative care centres to refuse to carry out any form...